Moderna Withheld Trial Data from FDA

That data showed its bivalent mRNA booster was less effective than the original, authorized anyway.

Everyone keeps saying to follow the money. Moderna chased the money. They withheld key trial data from the FDA to secure a $5 Billion dollar US Government contract during the bivalent approval process.

From CNN:

The pharmaceutical company Moderna didn’t present a set of infection data on the company’s new Covid-19 booster during meetings last year when …